mPhase Technologies has submitted a patent application to the US Patent and Trademark Office (USPTO) for its drug delivery system. The application covers a drug delivery system based on the company's Smart Surface technology, which ...
ScinoPharm and Foresee Pharmaceuticals have signed an agreement to form a joint venture for developing a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug used for treating prostate cancer. ...
QLT has signed an exclusive option agreement with Mati Therapeutics, granting it a 90-day option to acquire assets related to QLT's punctal plug drug delivery system (PPDS) technology for $500,000. The agreement will allow the company ...
Tags: QLT, Mati Therapeutics, PPDS technology, agreement
Aseptico, a manufacturer of portable dental equipments, has entered into an agreement to distribute Milestone Scientific' Single Tooth Anesthesia (STA ) System and all related disposable items in the US and Canada. In addition, both the ...
Tags: Aseptico, Milestone Scientific'Single Tooth Anesthesia System
InSite Vision has launched a new DuraSite 2 drug delivery system, designed to deliver ophthalmic therapeutics. DuraSite 2, which is based on InSite DuraSite technology, incorporates cataract surgery drug, ketorolac, a non-steroidal ...
Tags: InSite, Ophthalmic Drug Delivery System, ophthalmic therapeutics
Zogenix has commenced first IND clinical trial for Relday in patients with chronic, stable schizophrenia or schizoaffective disorder. Relday is based on a combination of its DosePro needle-free, subcutaneous drug delivery system with a ...
Tags: Clinical Trial, DosePro needle-free drug, pharmacokinetic
The subsidiary of Pristine Solutions, Eaton Scientific Systems, is planning to develop a transdermal patch delivery system for Tropine 3, a homatropine to treat non-hormonal hot flashes in pre-menopausal, peri-menopausal and post-menopausal ...
Tags: Transdermal Patch Delivery System, Eaton Scientific Systems, Tropine 3
Royer Biomedical(RBI)wins FDA approval to progress human testing of AppliGel-G(Gentamicin)in management of diabetic foot ulcers(DFU). The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has ...
BD has entered into a definitive agreement to purchase a developer of anti-needlestick devices for prefilled syringes, Safety Syringes. The acquisition will enable BD to provide Safety Syringe's UltraSafe Passive products to any ...